Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × Solutions × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Keratosis, Actinic 6 Neoplasms 5 Melanoma 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Hematologic Neoplasms 2 Hemangioma 2 Warts 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors Harboring NTRK Fusion 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Pelvic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Nonmelanoma Skin Cancers 1 Mucositis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lung Neoplasms 1

Interventions

Everolimus 15 Sirolimus 14 Cannabidiol 4 radiprodil 3 ganaxolone 3 Activator Appliances 3 Vigabatrin 2 Melatonin 2 exemestane 1 dactolisib 1 carbon-11 acetate 1 Urination 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Solutions 1 Simvastatin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Phlebotomy 1 Itraconazole 1 Injections 1 Genetic Testing 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Carbamazepine 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡